Marshall Wace LLP Grows Stake in Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB)
Marshall Wace LLP grew its position in Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Free Report) by 217.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 49,225 shares of the company’s stock after buying an additional 33,716 shares during the quarter. Marshall Wace LLP owned […]
Marshall Wace LLP grew its position in Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Free Report) by 217.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 49,225 shares of the company’s stock after buying an additional 33,716 shares during the quarter. Marshall Wace LLP owned […]
